PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Journal of Pathology and Translational Medicine10.4132/jptm.2016.11.172018522130-132Osteosarcomatous Differentiation in Rebiopsy Specimens of Pulmonary Adenocarcinoma with EGFR-TKI ResistanceHyein Ahn, Hyun Jung Kwon, Eunhyang Park, Hyojin Kim, Jin-Haeng Chunghttp://www.jpatholtm.org/upload/pdf/jptm-2016-11-17.pdf, http://www.jpatholtm.org/journal/view.php?doi=10.4132/jptm.2016.11.17, http://www.jpatholtm.org/upload/pdf/jptm-2016-11-17.pdf
Journal of Thoracic Oncology10.1016/j.jtho.2016.11.6012017121S496-S497P1.02-018 Osteosarcomatous Differentiation in the Rebiopsy Specimens of Patients Harboring Pulmonary Adenocarcinoma with EGFR-TKI ResistanceHyun Jung Kwon, Hyein Ahn, Eunhyang Park, Hyojin Kim, Jin-Haeng Chunghttps://api.elsevier.com/content/article/PII:S1556086416318421?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1556086416318421?httpAccept=text/plain
Respirology10.1111/resp.13207_406201722242-242REBIOPSY IN NON-SMALL CELL LUNG CANCER PATIENTS WITH ACQUIRED RESISTANCE TO EGFR-TKIhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fresp.13207_406, http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.13207_406/fullpdf
Respirology10.1111/resp.13420_241201823176-176DISCOVERY THE NOVEL COMPOUND FOR OVERCOMING EGFR-TKI RESISTANCE IN LUNG ADENOCARCINOMAhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fresp.13420_241, http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.13420_241/fullpdf
Journal of Thoracic Oncology10.1016/j.jtho.2018.10.08020181312S1072P063 STE029 Overcomes EGFR-TKI Resistance in Human Lung AdenocarcinomaL. Huang, Q. Zhouhttps://api.elsevier.com/content/article/PII:S1556086418332799?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1556086418332799?httpAccept=text/plain
Cell Death & Disease10.1038/s41419-018-1162-02018911APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinomaGuo-Shou Lu, Mengxia Li, Cheng-Xiong Xu, Dong Wanghttp://www.nature.com/articles/s41419-018-1162-0.pdf, http://www.nature.com/articles/s41419-018-1162-0, http://www.nature.com/articles/s41419-018-1162-0.pdf
Annals of Oncology10.1093/annonc/mdx671.017201728x130Different first line EGFR-TKI regimen and the clearance of EGFR sensitive mutation in acquired EGFR-TKI resistant lung adenocarcinoma patientsW. Zhuang, C. Xu, W. Wang, Z. Song, Y. Zhu, R. Chen, Y. Guan, X. Yi, M. Fang, G. Chen, T. Lv, Y. Songhttps://api.elsevier.com/content/article/PII:S092375341956402X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S092375341956402X?httpAccept=text/plain, http://academic.oup.com/annonc/article-pdf/28/suppl_10/mdx671.017/21936922/mdx671.017.pdf
Journal of Thoracic Oncology10.1016/j.jtho.2016.11.6162017121S507P1.02-033 Mesenchymal Transformation is the Most Common Histomorphologic Changes in the Rebiopsy of Lung Cancer Patients with EGFR-TKI ResistanceHyein Ahn, Hyun Jung Kwon, Eunhyang Park, Soo Young Park, Hyojin Kim, Se Hyun Kim, Jin-Haeng Chunghttps://api.elsevier.com/content/article/PII:S1556086416318573?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1556086416318573?httpAccept=text/plain
Guide to Targeted Therapies: Treatment Resistance in Lung Cancer10.1007/978-3-319-20741-4_4201537-50Overcoming EGFR-TKI ResistanceFederico Cappuzzohttp://link.springer.com/content/pdf/10.1007/978-3-319-20741-4_4
Lung Cancer10.1016/s0169-5002(13)70243-5201380S1022O REBIOPSY IN TKI-RESISTANCE: A RETROSPECTIVE ANALYSISJ. Kuiper, D. Heideman, E. Thunnissen, R. Paul, E. Smithttps://api.elsevier.com/content/article/PII:S0169500213702435?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500213702435?httpAccept=text/plain